Board Meeting30 Jul 2026, 05:11 pm
Torrent Pharma Declares Unaudited Financial Results for Q1 FY27
AI Summary
Torrent Pharmaceuticals Ltd announced the approval of its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, following a Board Meeting held on July 30, 2026. The company will publish extracts of these results and make them available on its website. Additionally, Ameera Shah will complete her term as an Independent Director on August 1, 2026. The financial results were reviewed by B S R & Co. LLP.
Key Highlights
- Board approved unaudited standalone and consolidated financial results.
- Results are for the quarter ended June 30, 2026.
- Limited review report from auditors is enclosed.
- Independent Director Ameera Shah completes her term on August 1, 2026.
Price Impact
More from TORNTPHARM